DBV Technologies raises new investment after stock dips

DBV Technologies said it intends to raise $194 million in new stock. It is a major biopharmaceutical giant known for innovative developments in pharmacology and bioengineering. The company intends to raise a stream of funds through private equity investments in publicly traded common stock and common stock purchase warrants.